ArticleThoracic cancer2021

Pathological complete response to neoadjuvant ceritinib of a crizotinib-resistant, stage IIIB non-small cell lung cancer with ALK rearrangement: A case report.

Zhongxing Bing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.